Sulkowski M - Search Results

1

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J. Soriano V, et al. Among authors: sulkowski m. AIDS. 2007 May 31;21(9):1073-89. doi: 10.1097/QAD.0b013e3281084e4d. AIDS. 2007. PMID: 17502718 Review. No abstract available.

2

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Soriano V, et al. Among authors: sulkowski m. AIDS. 2002 Apr 12;16(6):813-28. doi: 10.1097/00002030-200204120-00001. AIDS. 2002. PMID: 11919483 Review. No abstract available.

3

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.

Dieterich DT, Wasserman R, Bräu N, Hassanein TI, Bini EJ, Bowers PJ, Sulkowski MS. Dieterich DT, et al. Am J Gastroenterol. 2003 Nov;98(11):2491-9. doi: 10.1111/j.1572-0241.2003.08700.x. Am J Gastroenterol. 2003. PMID: 14638354 Clinical Trial.

4

Care of patients with hepatitis C and HIV co-infection.

Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J. Soriano V, et al. Among authors: sulkowski m. AIDS. 2004 Jan 2;18(1):1-12. doi: 10.1097/00002030-200401020-00001. AIDS. 2004. PMID: 15090824 Review. No abstract available.

5

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Sulkowski MS, et al. AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25. AIDS. 2005. PMID: 15802977

6

Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial.

Sulkowski MS, Dieterich DT, Bini EJ, Bräu N, Alvarez D, Dejesus E, Leitz GJ; HIV/HCV Coinfection Study Group. Sulkowski MS, et al. J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):504-6. doi: 10.1097/01.qai.0000167158.90722.73. J Acquir Immune Defic Syndr. 2005. PMID: 16010180 Clinical Trial. No abstract available.

7

Hepatitis C virus infection in HIV-infected patients.

Sulkowski MS. Sulkowski MS. Curr HIV/AIDS Rep. 2004 Sep;1(3):128-35. doi: 10.1007/s11904-004-0019-6. Curr HIV/AIDS Rep. 2004. PMID: 16091233 Review.

8

A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. Mehta SH, et al. Among authors: sulkowski ms. AIDS. 2005 Oct;19 Suppl 3:S179-89. doi: 10.1097/01.aids.0000192088.72055.90. AIDS. 2005. PMID: 16251816 Review.

9

Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness.

Sulkowski MS, Thomas DL. Sulkowski MS, et al. AIDS. 2005 Oct;19 Suppl 3:S8-12. doi: 10.1097/01.aids.0000192064.09281.48. AIDS. 2005. PMID: 16251833 Review. No abstract available.

10

Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.

Hornberger J, Torriani FJ, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K. Hornberger J, et al. J Clin Virol. 2006 Aug;36(4):283-91. doi: 10.1016/j.jcv.2006.04.008. Epub 2006 Jun 9. J Clin Virol. 2006. PMID: 16765638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

431 results

Search Page